1. Kok, Ken, Zwiers, Kimberley C, Boot, Rolf G, Aerts, Johannes M F G, Artola, Marta. 2021. Fabry Disease: Molecular Basis, Pathophysiology, Diagnostics and Potential Therapeutic Directions. In Biomolecules, 11, . doi:10.3390/biom11020271. https://pubmed.ncbi.nlm.nih.gov/33673160/
2. Chen, Qing, Xiao, Jianyu, Duan, Zhimin, Huang, Chengyin, Li, Min. 2020. Novel A4GALT gene variation with rare p phenotype in a compound heterozygous Chinese individual. In Transfusion, 61, E5-E6. doi:10.1111/trf.16163. https://pubmed.ncbi.nlm.nih.gov/33111355/
3. Shastry, Shamee, Satyamoorthy, Kapaettu, Acharya, Kiran V, Reghunathan, Dinesh, Joshi, Manjunath B. 2019. Deletion in the A4GALT Gene Associated with Rare "P null" Phenotype: The First Report from India. In Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie, 47, 186-189. doi:10.1159/000501916. https://pubmed.ncbi.nlm.nih.gov/32355479/
4. Lai, Yin-Ju, Wu, Wan-Yi, Yang, Chen-Ming, Lin, Marie, Yu, Lung-Chih. 2014. A systematic study of single-nucleotide polymorphisms in the A4GALT gene suggests a molecular genetic basis for the P1/P2 blood groups. In Transfusion, 54, 3222-31. doi:10.1111/trf.12771. https://pubmed.ncbi.nlm.nih.gov/25041587/
5. Ando, Reiko, Tokuda, Noriyo, Yamamoto, Tokunori, Goto, Momokazu, Furukawa, Koichi. 2016. Immunization of A4galt-deficient mice with glycosphingolipids from renal cell cancers resulted in the generation of anti-sulfoglycolipid monoclonal antibodies. In Glycoconjugate journal, 33, 169-80. doi:10.1007/s10719-016-9654-6. https://pubmed.ncbi.nlm.nih.gov/26883028/
智鼠故事 
